|
|
Post by itellthefuture777 on Feb 27, 2020 10:33:08 GMT -5
technovax.com/inhaled-powder-vaccines/
“Inhaled Powder” Vaccines
“Shelf-Stable, Self-Inhaled, Powderized” VLP Vaccines.
TechnoVax and MannKind Corp. have combined their respective technologies to create a Powder Formulation of VLP Influenza Vaccine for Intrapulmonary Self-Delivery by Inhalation.
No refrigeration is required, and because it is potentially self-administered public exposure is limited. In the event of an emerging pandemic the vaccine could be easily distributed to the population, greatly reducing the spread of the virus!
Advantages
◾Extended Shelf Life and Elimination of Cold Chain results in improved distribution costs and inventory management.
◾Best Route of Immunization (mucosal surface – respiratory tract)
◾Increased Patient Acceptance (inhaled vs. injection)
|
|
|
|
Post by goyocafe on Feb 27, 2020 10:43:24 GMT -5
He never talks about it.
|
|
|
|
Post by porkini on Feb 27, 2020 10:50:47 GMT -5
technovax.com/inhaled-powder-vaccines/
“Inhaled Powder” Vaccines
“Shelf-Stable, Self-Inhaled, Powderized” VLP Vaccines.
TechnoVax and MannKind Corp. have combined their respective technologies to create a Powder Formulation of VLP Influenza Vaccine for Intrapulmonary Self-Delivery by Inhalation.
No refrigeration is required, and because it is potentially self-administered public exposure is limited. In the event of an emerging pandemic the vaccine could be easily distributed to the population, greatly reducing the spread of the virus!
Advantages
◾Extended Shelf Life and Elimination of Cold Chain results in improved distribution costs and inventory management.
◾Best Route of Immunization (mucosal surface – respiratory tract)
◾Increased Patient Acceptance (inhaled vs. injection)
Is this a monthly discussion? mnkd.proboards.com/post/195696/thread |
|
|
|
Post by brotherm1 on Feb 27, 2020 10:50:56 GMT -5
iseethepast
|
|
|
|
Post by mnholdem on Feb 27, 2020 13:08:04 GMT -5
If you go to their Publications page, you'll see that their last publication was in 2013. The website has a 2020 copyright but it appears to have been left pretty much unaltered for 5-7 years.
|
|
|
|
Post by mango on Feb 27, 2020 13:20:17 GMT -5
Most recent publication by Jose M. Galarza, President and Founder of TechnoVax is November 2019. He represents himself as being with TechnoVax in the publication. I suspect nothing will ever happen between TechnoVax and MannKind. Hope I'm proved wrong one day... www.ncbi.nlm.nih.gov/m/pubmed/31505320/ |
|
|
|
Post by mnholdem on Feb 27, 2020 13:23:51 GMT -5
You would think that Technovax would post on link on their website.
|
|
|
|
Post by peppy on Feb 27, 2020 13:26:02 GMT -5
|
|
|
|
Post by longliner on Feb 27, 2020 15:43:29 GMT -5
What happened to the TechnoVax link Itell provided from 2019 about an award for pulminary vaccines? It kind of flew in the face of no recent news.
|
|
|
|
Post by mnholdem on Feb 27, 2020 17:04:49 GMT -5
I think he may have posted it on the TechnoVax thread.
|
|
